|
시장보고서
상품코드
1970506
분변 칼프로텍틴 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Faecal Calprotectin Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
분변 칼프로텍틴 검사 시장 규모는 2025년 51억 4,000만 달러에서 2026-2034년 CAGR 11.89%로 성장하여 2034년에는 141억 2,000만 달러에 달할 것으로 예측됩니다.
의료 서비스 제공업체가 소화기 질환의 조기 발견 및 모니터링에 중점을 두면서 분변 카프로텍티닌 검사 시장이 성장세를 보이고 있습니다. 장내 염증의 바이오마커인 카르프로텍티닌은 염증성 장질환(IBD), 크론병, 궤양성 대장염 등의 진단에 점점 더 많이 활용되고 있습니다. 전 세계적으로 만성 소화기 질환의 부담이 증가함에 따라 신뢰할 수 있는 비침습적 검사법에 대한 수요는 가속화될 것으로 예측됩니다.
기술의 발전으로 진단의 정확성과 효율성이 향상되고 있습니다. Point-of-Care 검사 키트는 신속한 결과 제공이 가능해 환자의 치료 순응도 향상과 적절한 치료 결정에 기여하고 있습니다. 자동화된 면역 측정법 및 ELISA 플랫폼은 실험실 업무를 효율화하고, 디지털 데이터 관리는 검사 결과와 전자 건강 기록의 통합을 실현하고 있습니다. 이러한 발전은 전 세계 의료 시스템에서 임상 결과와 업무 효율성을 모두 개선하고 있습니다.
향후 시장 확대는 맞춤형 의료와 예방의료에 의해 형성될 것입니다. 임상의들이 질병 관리를 위해 바이오마커 기반 접근법을 점점 더 많이 채택하고 있는 가운데, 대변 카프로텍티닌 검사는 대장내시경과 같은 침습적 시술을 줄이는 데 중요한 역할을 할 수 있습니다. 신흥 경제국에서는 인식의 향상과 헬스케어 인프라 확충에 힘입어 괄목할 만한 성장이 예상됩니다. 혁신성과 접근성이 보급을 촉진하는 가운데, 이 검사 시장은 전 세계 진단 환경에서 중요한 구성 요소로 자리매김하고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 분변 칼프로텍틴 검사 시장 : 어세이별
제5장 세계의 분변 칼프로텍틴 검사 시장 : 용도별
제6장 세계의 분변 칼프로텍틴 검사 시장 : 최종 용도별
제7장 세계의 분변 칼프로텍틴 검사 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
LSH 26.03.23The Faecal Calprotectin Testing Market size is expected to reach USD 14.12 Billion in 2034 from USD 5.14 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.
The faecal calprotectin testing market is gaining momentum as healthcare providers emphasize early detection and monitoring of gastrointestinal diseases. Calprotectin, a biomarker of intestinal inflammation, is increasingly used in diagnosing conditions such as inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. With the global burden of chronic digestive disorders on the rise, demand for reliable, non-invasive testing methods is expected to accelerate.
Technological progress is enhancing diagnostic accuracy and efficiency. Point-of-care testing kits are enabling rapid results, improving patient compliance, and supporting timely treatment decisions. Automated immunoassays and ELISA platforms are streamlining laboratory workflows, while digital data management is integrating test results with electronic health records. These advancements are improving both clinical outcomes and operational efficiency for healthcare systems worldwide.
Future market expansion will be shaped by personalized medicine and preventive healthcare. As clinicians increasingly adopt biomarker-based approaches for disease management, faecal calprotectin testing will play a crucial role in reducing invasive procedures such as colonoscopy. Emerging economies are expected to witness significant growth, supported by rising awareness and expanding healthcare infrastructure. With innovation and accessibility driving adoption, this testing market is positioned as a vital component of the global diagnostic landscape.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Assay
- Enzyme-linked Immunosorbent Assay
- Enzyme Fluroimmunoassay
- Quantitative Immunochromatography
By Application
- Inflammatory Bowel Disease
- Colorectal Cancer
- Others
By End-use
- Hospitals And Clinics
- Diagnostic Laboratories
- Academic And Research Institutes
COMPANIES PROFILED
- Epitope Diagnostics Inc, Hycult Biotech, Actim, Eagle Biosciences, Inc, Operon, Svar Life Science, Bhlmann, DRG International Inc, ALPCO, Diazyme Laboratories
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY ASSAY 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Assay
- 4.2. Enzyme-linked Immunosorbent Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Enzyme Fluroimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Quantitative Immunochromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Inflammatory Bowel Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-use
- 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Assay
- 7.2.2 By Application
- 7.2.3 By End-use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Assay
- 7.3.2 By Application
- 7.3.3 By End-use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Assay
- 7.4.2 By Application
- 7.4.3 By End-use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Assay
- 7.5.2 By Application
- 7.5.3 By End-use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Assay
- 7.6.2 By Application
- 7.6.3 By End-use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL FAECAL CALPROTECTIN TESTING INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Epitope Diagnostics Inc
- 9.2.2 Hycult Biotech
- 9.2.3 Actim, Eagle BiosciencesInc
- 9.2.4 Operon
- 9.2.5 Svar Life Science
- 9.2.6 BA1/4Hlmann
- 9.2.7 DRG International Inc
- 9.2.8 ALPCO
- 9.2.9 Diazyme Laboratories
